NM_001171613.2:c.149A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001171613.2(PREPL):​c.149A>G​(p.Asn50Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00227 in 1,613,670 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 9 hom. )

Consequence

PREPL
NM_001171613.2 missense

Scores

19

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.16

Publications

5 publications found
Variant links:
Genes affected
PREPL (HGNC:30228): (prolyl endopeptidase like) The protein encoded by this gene belongs to the prolyl oligopeptidase subfamily of serine peptidases. Mutations in this gene have been associated with hypotonia-cystinuria syndrome, also known as the 2p21 deletion syndrome. Several alternatively spliced transcript variants encoding either the same or different isoforms have been described for this gene.[provided by RefSeq, Jan 2010]
PREPL Gene-Disease associations (from GenCC):
  • hypotonia-cystinuria syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • myasthenic syndrome, congenital, 22
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030634105).
BP6
Variant 2-44343945-T-C is Benign according to our data. Variant chr2-44343945-T-C is described in ClinVar as Benign. ClinVar VariationId is 544540.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00236 (3443/1461372) while in subpopulation MID AF = 0.00382 (22/5762). AF 95% confidence interval is 0.00258. There are 9 homozygotes in GnomAdExome4. There are 1698 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PREPLNM_001171613.2 linkc.149A>G p.Asn50Ser missense_variant Exon 4 of 14 ENST00000409411.6 NP_001165084.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PREPLENST00000409411.6 linkc.149A>G p.Asn50Ser missense_variant Exon 4 of 14 1 NM_001171613.2 ENSP00000387095.2

Frequencies

GnomAD3 genomes
AF:
0.00141
AC:
214
AN:
152180
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00197
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00233
AC:
582
AN:
250034
AF XY:
0.00239
show subpopulations
Gnomad AFR exome
AF:
0.000569
Gnomad AMR exome
AF:
0.000784
Gnomad ASJ exome
AF:
0.0108
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000928
Gnomad NFE exome
AF:
0.00348
Gnomad OTH exome
AF:
0.00264
GnomAD4 exome
AF:
0.00236
AC:
3443
AN:
1461372
Hom.:
9
Cov.:
32
AF XY:
0.00234
AC XY:
1698
AN XY:
726994
show subpopulations
African (AFR)
AF:
0.000628
AC:
21
AN:
33436
American (AMR)
AF:
0.000784
AC:
35
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.0100
AC:
262
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86222
European-Finnish (FIN)
AF:
0.00126
AC:
67
AN:
53296
Middle Eastern (MID)
AF:
0.00382
AC:
22
AN:
5762
European-Non Finnish (NFE)
AF:
0.00255
AC:
2835
AN:
1111822
Other (OTH)
AF:
0.00306
AC:
185
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
162
323
485
646
808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00141
AC:
214
AN:
152298
Hom.:
1
Cov.:
33
AF XY:
0.00115
AC XY:
86
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41556
American (AMR)
AF:
0.000654
AC:
10
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.000941
AC:
10
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00197
AC:
134
AN:
68024
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00239
Hom.:
1
Bravo
AF:
0.00149
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00360
AC:
31
ExAC
AF:
0.00274
AC:
332
EpiCase
AF:
0.00218
EpiControl
AF:
0.00225

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Myasthenic syndrome, congenital, 22 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PREPL-related disorder Benign:1
Aug 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.062
DANN
Benign
0.88
DEOGEN2
Benign
0.015
.;.;.;T;T;T;T;.;.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.063
N
LIST_S2
Benign
0.74
T;.;.;.;.;.;T;T;T;T
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.0031
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
.;.;.;N;N;N;N;N;N;.
PhyloP100
-1.2
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.13
N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.038
Sift
Benign
0.31
T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.56
T;T;T;T;T;T;T;T;T;T
Polyphen
0.0, 0.0010
.;.;.;B;B;B;B;B;B;.
Vest4
0.063
MVP
0.14
MPC
0.0055
ClinPred
0.0033
T
GERP RS
-8.6
Varity_R
0.017
gMVP
0.14
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138555092; hg19: chr2-44571084; COSMIC: COSV53217039; COSMIC: COSV53217039; API